- Saturday, August 19, 2023
7:30 AM – 5:00 PM
Welcome
7:30 AM – 5:00 PM
Registration Hours
Location:Essex Foyer
8:00 AM – 8:15 AM
Welcome
8:00 AM – 8:15 AM
WelcomeLocation:Essex Center/SouthCo-Chair: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Co-Chair###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Co-Chair: – Massachusetts General Hospital Cancer Center
### 8:15 AM – 8:32 PM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - Yes
8:15 AM – 8:32 PM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - YesLocation:Essex Center/SouthPresenter: – City of Hope Comprehensive Cancer Center
Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center ### 902613###Presenter###Director of Judy and Bernard Briskin Center for Multiple Myeloma###City of Hope Comprehensive Cancer Center###Presenter: – City of Hope Comprehensive Cancer Center
### 8:32 AM – 8:49 AM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - No
8:32 AM – 8:49 AM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - NoLocation:Essex Center/SouthPresenter: – Sylvester Comprehensive Cancer Center, University of Miami
C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 1364707###Presenter###Professor of Medicine; Chief of Myeloma Division; Director of Sylvester Myeloma Research Institute; Leader of Experimental Therapeutics Program###Sylvester Comprehensive Cancer Center, University of Miami###Presenter: – Sylvester Comprehensive Cancer Center, University of Miami
### 8:49 AM – 9:00 AM
15 - Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy?
8:49 AM – 9:00 AM
Session 17: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - DiscussionLocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Panelist: – City of Hope Comprehensive Cancer Center
Panelist: – Sylvester Comprehensive Cancer Center, University of Miami
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center ### 902613###Panelist###Director of Judy and Bernard Briskin Center for Multiple Myeloma###City of Hope Comprehensive Cancer Center###Panelist: – City of Hope Comprehensive Cancer Center
### @@@ C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 1364707###Panelist###Professor of Medicine; Chief of Myeloma Division; Director of Sylvester Myeloma Research Institute; Leader of Experimental Therapeutics Program###Sylvester Comprehensive Cancer Center, University of Miami###Panelist: – Sylvester Comprehensive Cancer Center, University of Miami
### 9:00 AM – 9:35 AM
16 - Session 18: Optimal Frontline Therapy of Myeloma
9:00 AM – 9:35 AM
Session 18: Optimal Frontline Therapy of MyelomaLocation:Essex Center/SouthPresenter: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine ### 903003###Presenter###Clinical Professor of Medicine###Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine###Presenter: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
### 9:35 AM – 9:45 AM
Live Q&A
9:35 AM – 9:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine ### 903003###Speaker###Clinical Professor of Medicine###Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine###Speaker: – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine
### 9:45 AM – 9:50 AM
Exhibit Hall
9:50 AM – 10:50 AM
Non-CME Innvoation Theater
9:50 AM – 10:50 AM
Non-CME Innovation Theater - Sponsored by Genentech
Location:Essex North
10:50 AM – 11:00 AM
Exhibit Hall
10:50 AM – 11:00 AM
Exhibit Hall Break
11:00 AM – 11:35 AM
17 - Session 19: Optimizing Myeloma Therapies for Older and More Frail Patients
11:00 AM – 11:35 AM
Session 19: Optimizing Myeloma Therapies for Older and More Frail Patients Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute
Irene Ghobrial, MD – Dana-Farber Cancer Institute ### 1000158###Presenter###Professor of Medicine###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
###
11:35 AM – 11:45 AM
Live Q&A
11:35 AM – 11:45 AM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Dana-Farber Cancer Institute
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Irene Ghobrial, MD – Dana-Farber Cancer Institute ### 1000158###Speaker###Professor of Medicine###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
### 11:45 AM – 12:20 PM
20 - Session 20: Making Sense of the Choices in Relapsed Myeloma
11:45 AM – 12:20 PM
Session 20: Making Sense of the Choices in Relapsed MyelomaLocation:Essex Center/SouthPresenter: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Presenter###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Presenter: – Massachusetts General Hospital Cancer Center
### 12:20 PM – 12:30 PM
Live Q&A
12:20 PM – 12:30 PM
Live Q&ALocation:Essex Center/SouthSpeaker: – Massachusetts General Hospital Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Speaker###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Speaker: – Massachusetts General Hospital Cancer Center
### 12:30 PM – 12:35 PM
Exhibit Hall
12:30 PM – 12:35 PM
Break
12:35 PM – 1:35 PM
Non-CME Innvoation Theater
12:35 PM – 1:35 PM
Non-CME Innovation Theater - Sponsored by Janssen
Location:Essex North
1:35 PM – 2:10 PM
18 - Session 21: Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023
1:35 PM – 2:10 PM
Session 21: Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023Location:Essex Center/SouthPresenter: – Dana-Farber Cancer Institute
Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Presenter###Assistant Professor###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
### 2:10 PM – 2:20 PM
Live Q&A
2:10 PM – 2:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – Dana-Farber Cancer Institute
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Speaker###Assistant Professor###Dana-Farber Cancer Institute###Speaker: – Dana-Farber Cancer Institute
### 2:20 PM – 3:05 PM
19 - Session 22: Special Panel - Future of Myeloma
2:20 PM – 3:05 PM
Session 22: Special Panel - Future of MyelomaLocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Panelist: – Dana-Farber Cancer Institute
Panelist: – City of Hope
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Monique Hartley-Brown, MD, MMSc – Dana-Farber Cancer Institute ### 1983676###Panelist###Assistant Professor###Dana-Farber Cancer Institute###Panelist: – Dana-Farber Cancer Institute
### @@@ Michael Rosenzweig, MD – City of Hope ### 1830638###Panelist###Associate Professor of Medicine###City of Hope###Panelist: – City of Hope
### 3:05 PM – 3:35 PM
Exhibit Hall
3:05 PM – 3:35 PM
Exhibit Hall Break
3:35 PM – 4:10 PM
21 - Session 23: How Do I Diagnose and Treat AL Amyloidosis?
3:35 PM – 4:10 PM
Session 23: How Do I Diagnose and Treat AL Amyloidosis?Location:Essex Center/SouthPresenter: – City of Hope
Michael Rosenzweig, MD – City of Hope ### 1830638###Presenter###Associate Professor of Medicine###City of Hope###Presenter: – City of Hope
### 4:10 PM – 4:20 PM
Live Q&A
4:10 PM – 4:20 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – City of Hope
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Michael Rosenzweig, MD – City of Hope ### 1830638###Speaker###Associate Professor of Medicine###City of Hope###Speaker: – City of Hope
### 4:20 PM – 4:55 PM
Session 24: Optimal Management of MGUS and Smoldering Myeloma
4:20 PM – 4:55 PM
Session 24: Optimal Management of MGUS and Smoldering MyelomaLocation:Essex Center/SouthPresenter: – H.Lee Moffitt Cancer Center
Melissa Alsina, MD – H.Lee Moffitt Cancer Center ### 1864650###Presenter###Head, Myeloma Section###H.Lee Moffitt Cancer Center###Presenter: – H.Lee Moffitt Cancer Center
### 4:55 PM – 5:05 PM
Live Q&A
4:55 PM – 5:05 PM
Live Q&ALocation:Essex Center/SouthModerator: – Massachusetts General Hospital Cancer Center
Speaker: – H.Lee Moffitt Cancer Center
Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1577041###Moderator###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Moderator: – Massachusetts General Hospital Cancer Center
### @@@ Melissa Alsina, MD – H.Lee Moffitt Cancer Center ### 1864650###Speaker###Head, Myeloma Section###H.Lee Moffitt Cancer Center###Speaker: – H.Lee Moffitt Cancer Center
###
